ABIO - ARCA biopharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development14,07612,3487,063
Selling General and Administrative4,6364,2654,392
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-18,712-16,613-11,455
Income from Continuing Operations
Total Other Income/Expenses Net16716914
Earnings Before Interest and Taxes-18,545-16,444-11,441
Interest Expense664
Income Before Tax-18,551-16,444-11,445
Income Tax Expense-61--
Minority Interest---
Net Income From Continuing Ops-18,490-16,444-11,445
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,490-16,444-11,445
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,490-16,444-11,445